OUR STORY
Metabowlite LLC's research efforts center around health detection and monitoring. We provide users with our standalone system that takes advantage of the wealth of data available in urine to provide detailed biometric information. Armed with this data, physicians and caregivers are better equipped to provide patients with tailored treatment regimens.
Our technology is tailored to help the elderly. We work with retirement homes, convalescence, and skilled nursing facilities to mitigate health risk factors including dehydration, kidney complications, and urinary tract infections. By equipping our device, facilities are receiving complete UA profiles regularly.
Our interest sparked from personal stories relating to our loved ones and the implications of health-associated events through de-risking technologies.
Mohamed Faynus M.S.
Orlando Chirikian M.S. M.B.A.
Orlando Chirikian M.S. M.B.A.
Founder/CEO
Mohamed is an experienced research scientist in the field of medical technologies and cellular therapeutics. He has worked towards the development, production and scale-up of an ocular implant for treatment of blindness. Much of his career has focused on solving complex issues and bringing tangible solutions to patients. He has worked with several CMO and CROs in developing GMP pipelines for process improvement and production.
His expertise spans business development, stem cell technologies, device therapeutics and regulatory strategy and guidelines. Mohamed holds a BS in Forensic Biology from University of Toronto and an MS in Bioinformatics and Biotechnology from CSUCI. He is currently pursuing a Ph.D in Biomolecular Science and Engineering at UC Santa Barbara.
Orlando Chirikian M.S. M.B.A.
Orlando Chirikian M.S. M.B.A.
Orlando Chirikian M.S. M.B.A.
Founder/CFO
Orlando has extensive experience in administration and business development of geriatric healthcare facilities. He currently consults in business development and is an administrative officer for a large retirement facility caring for more than 200 residents. He is well versed and proven successful in fund raising and grant writing bringing in over $250,000 in funds for cardiac development and disease research. Orlando holds a BS in Biology from Loyola Marymount University and a dual masters (MS and MBA) in biotechnology from CSUCI. He currently is pursuing a Ph.D. in Biomolecular Science and Engineering at UC Santa Barbara.
Markus Merk M.S.
Orlando Chirikian M.S. M.B.A.
Markus Merk M.S.
Founder/CTO
Markus is an accomplished research scientist, engineer and chemist. His versatile background working with large pharmaceutical companies exemplifies his chemical domain expertise. Markus has contributed towards the de-novo synthesis of therapeutic molecules and the incumbent analytics. Markus is also well versed in fluidics and microfluidic systems engineering previously demonstrated in combination with skills in robotics and simulations. Markus received his BS in Chemistry and MS in Biochemistry from the University of Zurich Switzerland. He is currently pursuing a Ph.D in Biomolecular Science and Engineering at UC Santa Barbara.